We used anterior segment optical coherence tomography to investigate anterior chamber angle in primary angle-closure glaucoma (PACG) eyes following phacoemulsification and phacotrabeculectomy. Angle widening was significantly greater after phacoemulsification up to 6 months after the surgery.Purpose: To compare anterior chamber angle following 2 common surgeries for PACG.Methods: One hundred ten glaucoma patients were evaluated in this single center, prospective, randomized clinical trial. Those with concomitant PACG and senile cataract and without a history of ocular surgery, trauma, or chronic miotic use were recruited. Monocular patients were also excluded. Finally, 52 eligible subjects were randomly assigned to phacoemulsification ("Phaco" group, 25 eyes) or phacotrabeculectomy ("Combined" group, 27 eyes) surgeries. A swept-source, anterior segment optical coherence tomography device (CASIA SS-1000 OCT) was used to image the anterior segment. Mask graders used the images to measure the following parameters before and 1 week, 1 month, and 6 months after surgery: angle opening distance at 500 µm, trabecular iris surface area at 500 µm, and trabecular iris angle at 500 µm.Results: There was no significant difference between study groups regarding best-corrected visual acuity, intraocular pressure (IOP), and the number of glaucoma medications in preoperative or postoperative visits (P > 0.076). Also, the measured angle parameters were not statistically significantly different between the 2 groups before surgery (P > 0.123). After surgery, all measured parameters were significantly increased in both groups (P < 0.0001). At the 6-month follow-up, nasal angle opening distance at 500 µm was 0.383 ± 0.027 vs. 0.349 ± 0.017, trabecular iris surface area at 500 µm was 0.141 ± 0.007 vs. 0.125 ± 0.005, and trabecular iris angle at 500 µm was 40.1 ± 12.9 vs. 34.6 ± 3.1 in Phaco and Combined groups, respectively (P < 0.0001 for all).Conclusions: Anterior chamber angle widening by anterior segment optical coherence tomography was observed in PACG patients following surgery and was significantly greater after phacoemulsification compared with combined phacotrabeculectomy at all time points. Similar IOP and medication burden were noted for up to 6 months as secondary outcomes. The contribution of angle changes to the IOP-lowering effect of phacoemulsification in PACG eyes needs further study.